{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:57:10Z","timestamp":1793105830511,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.thromres.2015.04.023","type":"journal-article","created":{"date-parts":[[2015,4,26]],"date-time":"2015-04-26T02:58:04Z","timestamp":1430017084000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effectiveness of and risk associated with aspirin therapy in hemodialysis patients with a background of antiplatelet factor 4\/heparin complex antibody detection"],"prefix":"10.1016","volume":"136","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2015.04.023_bb0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1373\/clinchem.2013.207142","article-title":"High-sensitivity troponin as a predictor of cardiac events and mortality in the stable dialysis population","volume":"60","author":"Hassan","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.thromres.2015.04.023_bb0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.05.012","article-title":"Long-term Morbidity and Mortality of Carotid Endarterectomy in Patients with End-stage Renal Disease Receiving Hemodialysis","volume":"23","author":"Okawa","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.thromres.2015.04.023_bb0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","article-title":"Acute myocardial infarction and renal dysfunction: a high-risk combination","volume":"137","author":"Wright","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2015.04.023_bb0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","article-title":"Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients","volume":"137","author":"Shlipak","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2015.04.023_bb0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1525-139X.2006.00176.x","article-title":"When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients","volume":"19","author":"Chang","year":"2006","journal-title":"Semin Dial"},{"issue":"1","key":"10.1016\/j.thromres.2015.04.023_bb0030","article-title":"Heparin-induced thrombocytopenia","volume":"30","author":"Greinacher","year":"2010","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.thromres.2015.04.023_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1054\/blre.2001.0189","article-title":"Heparin-induced thrombocytopenia: an overview","volume":"16","author":"Kelton","year":"2002","journal-title":"Blood Rev"},{"key":"10.1016\/j.thromres.2015.04.023_bb0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-0037-1615864","article-title":"Heparin-induced thrombocytopenia: a clinicopathologic syndrome","volume":"82","author":"Warkentin","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.04.023_bb0045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(94)91797-3","article-title":"Heparin-associated thrombosis despite normal platelet counts","volume":"344","author":"Hach-Wunderle","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2015.04.023_bb0050","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0140-6736(05)65684-X","article-title":"Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis","volume":"348","author":"Greinacher","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2015.04.023_bb0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajh.10032","article-title":"Frequency of anti-heparin-platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis","volume":"69","author":"O'Shea","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2015.04.023_bb0060","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.surg.2004.07.004","article-title":"Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients","volume":"136","author":"Mureebe","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.thromres.2015.04.023_bb0065","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/hrt.2008.160549","article-title":"Thrombotic events in patients with antiplatelet factor 4\/heparin antibodies","volume":"95","author":"Mattioli","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2015.04.023_bb0070","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ahj.2008.11.007","article-title":"Heparin\/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up","volume":"157","author":"Mattioli","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2015.04.023_bb0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.thromres.2006.09.014","article-title":"The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis","volume":"120","author":"Carrier","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2015.04.023_bb0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jvs.2008.03.028","article-title":"Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia","volume":"48","author":"Alexy","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.thromres.2015.04.023_bb0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5002631","article-title":"Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex","volume":"73","author":"Carrier","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.thromres.2015.04.023_bb0090","first-page":"CD008834","article-title":"Antiplatelet agents for chronic kidney disease","volume":"2","author":"Palmer","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.thromres.2015.04.023_bb0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000346710","article-title":"Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study","volume":"37","author":"Schneider","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.thromres.2015.04.023_bb0100","doi-asserted-by":"crossref","first-page":"e62239","DOI":"10.1371\/journal.pone.0062239","article-title":"The clinical significance and risk factors of anti-platelet factor 4\/heparin antibody on maintenance hemodialysis patients: a two-year prospective follow-up","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2015.04.023_bb0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2040620712443537","article-title":"Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia","volume":"3","author":"Bakchoul","year":"2012","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.thromres.2015.04.023_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0268-960X(91)90031-7","article-title":"Platelet procoagulant activity: physiological significance and mechanisms of exposure","volume":"5","author":"Bevers","year":"1991","journal-title":"Blood Rev"},{"key":"10.1016\/j.thromres.2015.04.023_bb0115","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1538-7836.2007.02866.x","article-title":"Reciprocal regulation of platelet responses to P2Y and thromboxane receptor activation","volume":"6","author":"Barton","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2015.04.023_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(02)02925-4","article-title":"Anti-thrombin action of low-dose acetylsalicylic acid","volume":"460","author":"Di Micco","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.thromres.2015.04.023_bb0125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/(SICI)1096-8652(199608)52:4<288::AID-AJH8>3.0.CO;2-O","volume":"52","author":"Rand","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2015.04.023_bb0130","first-page":"E55","article-title":"Measurement of platelet-derived microparticle levels in the chronic phase of cerebral infarction using an enzyme-linked immunosorbent assay","volume":"54","author":"Shirafuji","year":"2008","journal-title":"Kobe J Med Sci"},{"key":"10.1016\/j.thromres.2015.04.023_bb0135","first-page":"335","article-title":"Treatment of heparin-induced thrombocytopenia: an overview","author":"Greinacher","year":"2004"},{"key":"10.1016\/j.thromres.2015.04.023_bb0140","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ajh.20305","article-title":"Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin","volume":"78","author":"Selleng","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2015.04.023_bb0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1540-8183.2008.00363.x","article-title":"Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation","volume":"21","author":"Bream-Rouwenhorst","year":"2008","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.thromres.2015.04.023_bb0150","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/asheducation-2008.1.236","article-title":"Thrombophilia states and markers of coagulation activation in the prediction of pediatric venous thromboembolic outcomes: a comparative analysis with respect to adult evidence","author":"Goldenberg","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.thromres.2015.04.023_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0404.2008.01081.x","article-title":"Is D-dimer helpful in evaluating stroke patients? A systematic review","volume":"119","author":"Haapaniemi","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.thromres.2015.04.023_bb0160","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4065\/80.8.995","article-title":"Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study","volume":"80","author":"Pena de la Vega","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.thromres.2015.04.023_bb0165","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2215\/CJN.00810209","article-title":"Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates","volume":"4","author":"Hiremath","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815001954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815001954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T03:53:03Z","timestamp":1566618783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384815001954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0049384815001954"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2015.04.023","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of and risk associated with aspirin therapy in hemodialysis patients with a background of antiplatelet factor 4\/heparin complex antibody detection","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2015.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}